We dont really know the whole truth about antigen specificity driving TIL efficacy. We know that some of the tumor-reactive TILs represent neoantigen-specific T cells, [whereas] some represent more shared or tumor-associated antigens and some may be viral antigens; however, there is also a population of these tumor-reactive T cells that are still unknown to us, Svane explained.
A science-based video game is looking for players to help train its algorithm so that it can detect cancerous cells from just an image. AcCELLerate, as the game is known, requires players to trace over photos of dye-stained tongues using a smartphone or mouse, which isnt as gross as it sounds.
The new regulation makes it possible to conduct research on human embryos that are at more advanced stages of development For 40 years, research into early human development has been guided by the principle that after 14 days, an embryo should not be used for research and must be destroyed. This rule has been part of the law of more than 12 countries. But new guidelines released by the International Society for Stem Cell Research have removed this rule.
DUBLIN, July 2, 2021 /PRNewswire/ -- The "Global Fetal Bovine Serum Market 2020-2026" report has been added to ResearchAndMarkets.com's offering. The global market for fetal bovine serum is projected to have a considerable CAGR during the forecast period
The Federal Minister for Health and Aged Care, the Hon Greg Hunt, has announced$18.7 million in funding for the 2020 Stem Cell Mission, which focuses on research that develops and delivers innovative, safe and effective stem cell medicines to improve health outcomes.
BOSTON, July 1, 2021 /PRNewswire/ -- Last week on June 21 with the start of its participation in the virtual 2021 Annual Meeting of the International Society for Stem Cell Research, stem cell biotechnology company Asymmetrex launched a new web portal that provides scientists free online access to calculators for important parameters used in human tissue cell research. In a June 30 post, business and technology news platform SuperbCrew interviewed Asymmetrex's President and CEO James Sherley, M.D., Ph.D
For 40 years, research into early human development has been guided by the principle that after 14 days, an embryo should not be used for research and must be destroyed.
Results showed percutaneous implantation of allogeneic bone-forming cells was well tolerated in patients and led to promising radiological and clinical improvements Gosselies, Belgium, 30June 2021, 7am CEST BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the cell therapy company addressing unmet medical needs in orthopedics and other diseases, today announces it has published the results of its Phase I/IIa clinical trial with ALLOB, Bone Therapeutics allogeneic bone cell therapy, in patients with delayed union fractures. The results were published in Stem Cell Research & Therapy, the international peer-reviewed journal focusing on translational research in stem cell therapies. Approximately 5 to 10% of all long bone fractures do not heal adequately, evolving to delayed union and nonunion fractures
Using an experimental model to simulate the blood-brain barrier, scientists in Sweden reported in unprecedented detail how antioxidants protect the brain from inflammation caused by neurodegenerative diseases such as Alzheimer's and Parkinson's. The study, conducted as a proof of concept by brain model developers at KTH Royal Institute of Technology in Stockholm, showed in minute-by-minute detail how the blood-brain barrier reacts to high levels of inflammation after the administration of a next-generation derivative of the widely-used anti-inflammatory drug, NAC (N-acetylcysteine).
Innovative gene-editing therapies for two significant blood disorders, beta thalassemia and sickle cell anaemia, have received a boost with the AKUs Centre for Regenerative Medicine and Stem Cell Research, CRM, winning a competitive research grant of Rs159.60 million ($1.02 m) to look for a genetic fix.
Recent Comments